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Abstract Abstracted
• Huntington’s disease is neurodegenerative disease caused by a single
mutation in the Huntingtin gene
• The number of CAG repeats can be used to predict the severity of
degeneration in the brain as well the age of disease onset
• Disease progression can be defined in terms of a number of variables
(including performance on tests and brain volume), but the most
basic one is time
• Langbehn et al. found that putamen and caudate volumes best
tracked disease progression at any given time
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• Therefore, Huntington’s disease
is inherently a genetic disease
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• Huntington’s disease is a
neurodegenerative disease
characterized by expansion of
the CAG trinucleotide sequence
in the huntingtin gene of
chromosome 4
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Introduction

Intracellular and extracellular inclusions develop
(Jimenez-Sanchez et al., 2017)

↓ brain volume in the striatum
(Alila Medical, 2021)

Introduction
• The primary clinical markers of the disease
are cognitive and motor deficits
• Perform worse on a tapping task
• Perform worse on a Stroop word reading task

• The expression of the disease
symptomatically based on the genetic
underpinning is known as penetrance
•
•
•
•

10-26 repeats → no penetrance
26-25 repeats → intermediate penetrance
39-39 repeats → reduced penetrance
40+ repeats → full penetrance

Introduction
• Langbehn et al. claim that few disease characteristics can be
determined using just the CAG repeat length and age
• The goal of the research was to determine the clinical and
morphometric implications of CAG repeat length
• Hopefully, the results would help determine:
• 1. Which variables are best associated with CAG repeat length and age
(highest R2)
• 2. How the progression of Huntington’s disease looks like (Quadratic? Linear?
Flat?)

Methods
• The researchers did not sample individuals themselves
• Rather, they obtained data through the TRACK-HD/TRACK-ON studies
TRACK-HD

TRACK-ON

• four academic institutions first recruited 123
healthy controls, 120 pre-HD carriers, and 123
with early HD subjects

• a follow up of TRACK
• still occurring
• maximum time of consideration: 6 years

Combined
• 2065 patient visits
• 443 participants
• Used UHDRS variables + morphometric data

Methods
• UHDRS – Clinical
• A clinical battery of tests used
to assess disease severity
• Involves motor, cognitive, and
neuropsychiatric tasks/tests
• 74 total items

• Morphometric data (MRI)
• Brain volumes (caudate and
putamen, total brain volume)
• Given that people naturally
have different-sized heads, the
ratios of these volumes to the
total intracranial volume
𝑉𝑜𝑙𝑢𝑚𝑒 𝐶𝑜𝑛𝑠𝑖𝑑𝑒𝑟𝑒𝑑 =

𝐴𝑐𝑡𝑢𝑎𝑙 𝑉𝑜𝑙𝑢𝑚𝑒
𝑇𝑜𝑡𝑎𝑙 𝐼𝑛𝑡𝑟𝑎𝑐𝑟𝑎𝑛𝑖𝑎𝑙 𝑉𝑜𝑙𝑢𝑚𝑒

Methods
• Principal component analysis
was used to derive summary
scores for clinical and
morphometric data
• “the weighted sum of the
original set of variables that
has the highest possible mean
correlation with those same
variables”
• That statistics themselves are
described using linear algebra

Results
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Results

• Previous graphs depicted motor-cognitive, caudate-putamen, and gray matter
scores as a function of time
• These graphs indicate the relationship between the PCs themselves
• The inflection point at PC = 0 indicates shift from healthy to HD subjects

Conclusion
• Phenotype declines in a CAG-dependent
manner

Clinical

• However, different acceleration rates
between CAG repeat lengths indicate that a
relationship is present

• Clinical predictors do not as strongly track
disease progression as morphometric
predictors do
• Variance can be decreased using a smaller
subset of variables
• Neurodegeneration in the caudate and
putamen is linear over time

Genetic

Biological

Discussion Questions
• Why do you think brain matter volume tracked age in a quadratic
manner?
• Why do you think neurodegenerative diseases have no cure? (Keep in
mind genetics)
• What directions do think neuroscience/neurology should take in the
future?
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